Emcure Pharmaceuticals Limited (NSE:EMCURE)

Emcure Pharmaceuticals Statistics

Total Valuation

NSE:EMCURE has a market cap or net worth of INR 281.44 billion. The enterprise value is 294.33 billion.

Market Cap	281.44B
Enterprise Value	294.33B

Important Dates

The next estimated earnings date is Wednesday, February 4, 2026.

Earnings Date	Feb 4, 2026
Ex-Dividend Date	Aug 14, 2025

Share Statistics

NSE:EMCURE has 189.57 million shares outstanding. The number of shares has increased by 3.59% in one year.

Current Share Class	189.57M
Shares Outstanding	189.57M
Shares Change (YoY)	+3.59%
Shares Change (QoQ)	-0.03%
Owned by Insiders (%)	72.80%
Owned by Institutions (%)	5.08%
Float	25.12M

Valuation Ratios

The trailing PE ratio is 35.46 and the forward PE ratio is 27.30. NSE:EMCURE's PEG ratio is 1.05.

PE Ratio	35.46
Forward PE	27.30
PS Ratio	3.33
PB Ratio	5.76
P/TBV Ratio	7.54
P/FCF Ratio	55.47
P/OCF Ratio	37.64
PEG Ratio	1.05

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.57, with an EV/FCF ratio of 58.01.

EV / Earnings	37.11
EV / Sales	3.48
EV / EBITDA	18.57
EV / EBIT	24.59
EV / FCF	58.01

Financial Position

The company has a current ratio of 1.52, with a Debt / Equity ratio of 0.34.

Current Ratio	1.52
Quick Ratio	0.79
Debt / Equity	0.34
Debt / EBITDA	1.05
Debt / FCF	3.27
Interest Coverage	14.17

Financial Efficiency

Return on equity (ROE) is 17.84% and return on invested capital (ROIC) is 15.24%.

Return on Equity (ROE)	17.84%
Return on Assets (ROA)	8.54%
Return on Invested Capital (ROIC)	15.24%
Return on Capital Employed (ROCE)	20.98%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	12.55M
Profits Per Employee	1.18M
Employee Count	6,731
Asset Turnover	0.96
Inventory Turnover	1.70

Taxes

In the past 12 months, NSE:EMCURE has paid 3.03 billion in taxes.

Income Tax	3.03B
Effective Tax Rate	27.01%

Stock Price Statistics

The stock price has increased by +15.60% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+15.60%
50-Day Moving Average	1,437.52
200-Day Moving Average	1,331.17
Relative Strength Index (RSI)	49.17
Average Volume (20 Days)	242,132

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:EMCURE had revenue of INR 84.49 billion and earned 7.93 billion in profits. Earnings per share was 41.87.

Revenue	84.49B
Gross Profit	50.07B
Operating Income	11.97B
Pretax Income	11.23B
Net Income	7.93B
EBITDA	15.38B
EBIT	11.97B
Earnings Per Share (EPS)	41.87

Balance Sheet

The company has 5.12 billion in cash and 16.59 billion in debt, with a net cash position of -11.47 billion or -60.51 per share.

Cash & Cash Equivalents	5.12B
Total Debt	16.59B
Net Cash	-11.47B
Net Cash Per Share	-60.51
Equity (Book Value)	48.84B
Book Value Per Share	250.31
Working Capital	19.19B

Cash Flow

In the last 12 months, operating cash flow was 7.48 billion and capital expenditures -2.40 billion, giving a free cash flow of 5.07 billion.

Operating Cash Flow	7.48B
Capital Expenditures	-2.40B
Free Cash Flow	5.07B
FCF Per Share	26.76

Margins

Gross margin is 59.26%, with operating and profit margins of 14.17% and 9.39%.

Gross Margin	59.26%
Operating Margin	14.17%
Pretax Margin	13.29%
Profit Margin	9.39%
EBITDA Margin	18.20%
EBIT Margin	14.17%
FCF Margin	6.00%

Dividends & Yields

This stock pays an annual dividend of 3.00, which amounts to a dividend yield of 0.20%.

Dividend Per Share	3.00
Dividend Yield	0.20%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	7.17%
Buyback Yield	-3.59%
Shareholder Yield	-3.39%
Earnings Yield	2.82%
FCF Yield	1.80%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3